title: Hippocampal injections of amyloid beta-peptide 1-40 impair subsequent one-trial/day reward learning.
abstract: The injection of amyloid beta-peptide (Abeta) into rat CNS has been reported to induce cellular neuropathology. The present study investigated whether multiple intrahippocampal injections of Abeta 1-40 would impair one-trial/day reward learning 14 days later. Twenty-four male Sprague-Dawley rats, 3-4 months old, were injected with either Abeta 1-40 or distilled water into seven hippocampal sites bilaterally. Ten rats received 3 nmol Abeta 1-40 in 2 microl of distilled water per injection site, while 14 rats received distilled water alone. Following a 9-day recovery period, rats were gradually food deprived to 82% of their initial body weight. Fourteen days after the intrahippocampal injection, all rats received an initial training trial and three subsequent daily retention trials. Rats receiving Abeta 1-40 were significantly impaired on the second retention trial in terms of accuracy (number of unbaited alleys entered) and on the second and third retention trials in terms of speed (reciprocal of latency to reward). Histological analysis showed that Abeta 1-40 injections produced significant neuronal loss and gliosis. Abeta 1-40 immunoreactivity persisted locally at the injection site and in macrophages 2 weeks following the hippocampal injections. These effects appear to be sequence-specific; rats receiving Abeta 1-42 with a scrambled peptide sequence did not differ significantly from rats receiving distilled water alone in retention of the learning task or degree of histological damage.
authors.affiliation: University of Houston, Clear Lake, Houston, Texas 77058, USA. MALIN@CL.UH.EDU
authors.forename: D H
authors.initials: DH
authors.lastname: Malin
authors.forename: M K
authors.initials: MK
authors.lastname: Crothers
authors.forename: J R
authors.initials: JR
authors.lastname: Lake
authors.forename: P
authors.initials: P
authors.lastname: Goyarzu
authors.forename: R E
authors.initials: RE
authors.lastname: Plotner
authors.forename: S A
authors.initials: SA
authors.lastname: Garcia
authors.forename: S H
authors.initials: SH
authors.lastname: Spell
authors.forename: B J
authors.initials: BJ
authors.lastname: Tomsic
authors.forename: T
authors.initials: T
authors.lastname: Giordano
authors.forename: N W
authors.initials: NW
authors.lastname: Kowall
mesh_terms: D000544:Alzheimer Disease / Q000473:pathology; D000818:Animals; D002352:Carrier Proteins / Q000009:adverse effects*; D004193:Discrimination Learning / Q000187:drug effects*; D004195:Disease Models, Animal; D005911:Gliosis / Q000139:chemically induced / Q000473:pathology; D006624:Hippocampus / Q000187:drug effects*; D007267:Injections; D008297:Male; D009410:Nerve Degeneration / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012153:Retention, Psychology / Q000187:drug effects; D012201:Reward
chemical_list: D002352:Carrier Proteins